1. Home /
  2. Business service /
  3. Crinetics Pharmaceuticals

Category



General Information

Locality: San Diego, California

Phone: +1 858-450-6464



Address: 10222 Barnes Canyon Road 92121 San Diego, CA, US

Website: crinetics.com/

Likes: 904

Reviews

Add review

Facebook Blog





Crinetics Pharmaceuticals 12.02.2021

Congenital #hyperinsulinism is tough to diagnose, but considering the majority of patients with congenital HI end up with a developmental delay or defect, timely recognition, diagnosis and treatment are crucial. Learn the signs of this #raredisease

Crinetics Pharmaceuticals 05.02.2021

Founded in endocrine research, Crinetics is committed to developing treatments that have a positive impact on the lives of #raredisease patients. Paltusotine, our investigational drug for #acromegaly, is starting Phase 3 clinical trials, and that’s just one example of the important work we're doing to combat endocrine disease.

Crinetics Pharmaceuticals 03.02.2021

Crinetics is pleased to announce that our company’s oral ACTH antagonist for the treatment of Cushing’s disease and Congenital Adrenal Hyperplasia (CAH), has advanced into Phase I study. This treatment has the potential to offer patients with Cushing’s disease, CAH, and related diseases a life-saving treatment option. #RareDisease

Crinetics Pharmaceuticals 25.01.2021

Crinetics is proud to partner with Pituitary World News for the Second Annual Virtual Patient Gathering Saturday, Feb. 6, 2021 - Noon to 3pm EST ( 9am-Noon PST) For More Info: http://bit.ly/2YEvpwP

Crinetics Pharmaceuticals 04.11.2020

Crinetics announced that the #FDA has granted rare pediatric disease designation (RPD) for CRN04777, an sst5 agonist being developed for congenital #hyperinsulinism. Congenital HI is a devastating #raredisease in which infants are born with life threatening hypoglycemia due to excess insulin secretion. A Phase 1 clinical study of CRN04777 is planned for in early 2021. Read more here: https://crinetics.com/crinetics-pharmaceuticals-receives-r/ Under the FDA’s Rare Pediatric Disease Priority Review Voucher Program, companies may be eligible to receive a priority review voucher following approval of a product with an RPD designation. #pediatrics #hypoglycemia #insulin

Crinetics Pharmaceuticals 23.10.2020

We are pleased to welcome Adriana to the executive team to lead our Human Resource function." - Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics

Crinetics Pharmaceuticals 15.10.2020

Every year at Crinetics, we take a company photo, a moment in time when we are all together (with our pups). This year, of course, we’ve spent much of the spring apart, but we wanted to show that now more than ever we’re still together, working for our patients every day.

Crinetics Pharmaceuticals 25.09.2020

Support Groups vs Self Help Groups - Navigate the difference

Crinetics Pharmaceuticals 13.09.2020

In Faces of Acromegaly, courtesy of Acromegaly Community, 23 people living with acromegaly share their before and after photos and share some insight on living with the Acromegaly: from symptoms to treatment, to messages of hope.

Crinetics Pharmaceuticals 11.09.2020

Crinetics Pharmaceuticals reports positive interim results for the Acrobat Edge Phase 2 Trial of Paltusotine (CRN00808) In Acromegaly Patients

Crinetics Pharmaceuticals 09.09.2020

Cushing’s disease results from a pituitary tumor that oversecretes the hormone ACTH, which in turn causes over-secretion of cortisol. Cortisol is the body’s main stress hormone. The effects of having too much cortisol include getting excess fat deposits in the collarbone, back of neck, face, and trunk, excessive sweating, thinning of the skin, muscle weakness, extra hair growth, depression/anxiety, high blood pressure, osteoporosis, high blood sugar, and heart disease. Untreated, it can lead to an early death.

Crinetics Pharmaceuticals 20.08.2020

Sending Special Thanks To Acromegaly Community

Crinetics Pharmaceuticals 04.08.2020

It was great to have students from Miramar College Chemistry Club visit us last Friday. We love seeing the future of science.

Crinetics Pharmaceuticals 24.07.2020

2nd Podcast in this Great New Series - gives an unfettered look at efforts to develop new drugs to solve unmet needs in acromegaly, Cushing’s and rare neuroendocrine diseases.

Crinetics Pharmaceuticals 21.07.2020

We are honored to be part of Pituitary World News brand new podcast series

Crinetics Pharmaceuticals 11.07.2020

It’s a great thing when our work brings us to Philadelphia to support this wonderful organization, CHI Congenital Hyperinsulinism International at their annual Sugar Soiree benefit. Generous donations from this event allow CHI to continue to raise awareness to increase timely diagnosis, provide educational opportunities, support HI families and help them access the care they need, and support research. It really is the #SweetestCause

Crinetics Pharmaceuticals 09.07.2020

Crinetics showing our support for Acromegaly Awareness Day Big thanks to Jill Sisco, President of Acromegaly Community for joining us!